WinstonWınston
McGraw Hill logo

McGraw Hill

MH
38
Education & Training Services · Consumer Defensive
Winston Score
38
Winston is serious
Below-average fundamentals — multiple weak pillars.

McGraw Hill makes educational materials for students and teachers. Its main products are textbooks, digital learning platforms, and online homework and assessment tools. The company sells mostly to colleges and universities in the United States, but also serves K-12 schools and international markets.

McGraw Hill earns money by selling digital subscriptions and course materials directly to students, and by licensing its content to schools and institutions. Most of its revenue comes from North America, and the company competes with Pearson and Cengage in the higher education market. Its large library of academic content and deep relationships with university faculty give it some staying power, but the company carries significant debt from a leveraged buyout, which explains its negative return on invested capital. The key risk is that open-access textbooks and free online resources continue to pressure pricing and reduce demand for paid course materials.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+12.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-7.9% YoY

YoY Growth Rate

Earnings declining

Insider Activity

87.2%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~12 months

$390M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Adequate runway but may need to raise capital within 2 years

Growth context

McGraw Hill is growing revenue at 13% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
83.4%
Premium pricing power — 83.4% gross margin
Operating Margin
5.9%
Thin — 5.9% operating margin
ROCE
0.8%
Weak — 0.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+3.2%
Slow sales growth (3.2% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
15.0%
Converts sales into free cash efficiently (15.0%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
11.34
Heavy debt load (11.34)
Interest Cover
1.38x
Dangerous — barely covers interest (1.4x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
55.4x
no trend
Expensive — P/E 55.4

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+50.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (55.4 → 5.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial